Clinical trial
Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of…
NCT00295477 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00295477 |
|---|---|
| Title | Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV |
| Official title | A Phase I/II, Open-label, Single Center Study to Evaluate the Tolerability, Trafficking and Therapeutic Effects of Repeated Doses of Autologous T Cells Transduced With VRX496 in HIV Infected Subjects |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Genetic |
| Interventions | VRX496 |
| Enrollment | 25 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2010 |
| Completion | Dec 1, 2013 |
| First posted | Feb 23, 2006 |
| Last update posted | Oct 23, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: